Pinar Karaca Mandic

Pinar Karaca Mandic

Professor, C. Arthur Williams Jr. Professor in Healthcare Risk Management


  • PhD 2004
    Economics, University of California at Berkeley
  • BA 1998
    Economics and Mathematics, High Honors, Swarthmore College


  • Health Economics
  • Health Insurance
  • Medical Technology
  • Pharmaceutical Use and Prescribing
  • Clinical Evidence Diffusion


Professor Pinar Karaca-Mandic (she/her/hers) teaches healthcare marketplace and medical technology evaluation. She is the C. Arthur Williams Jr. Professor in Healthcare Risk Management, and the Academic Director of the Medical Industry Leadership Institute (MILI) in the Department of Finance. 

She is a Research Associate at the National Bureau of Economic Research (NBER), in Health Economics and Healthcare programs. She also serves as an Associate Editor of Forum for Health Economics and Policy, and an Editorial Board Member for the International Journal of Health Economics and Management. 

As a health economist, her vision is to improve "value" in healthcare. Guided by this vision, her research made contributions to the literature in four key areas to understand: 1) Value and diffusion of medical technologies; 2) Uptake of clinical guidelines and response to evidence on safety and effectiveness; 3) Access and affordability of healthcare and role of health insurance marketplace; 4) Assessing competition, frictions and their impact in quality and costs. These areas dynamically interact with each other, and involve and interplay of healthcare consumers, patients, physicians, healthcare organizations, medical technology producers as well as public and private third-party payers. Her research examines interactions between these components and examines the impact of regulation and market incentives.  

Dr. Karaca-Mandic’s research has been published in leading economics, medical and health policy journals including the Journal of Political Economy, Journal of Risk and Insurance, Journal of Health Economics, Health Economics, Journal of the American Medical Association (JAMA), British Medical Journal, Health Services Research and Health Affairs. Her research has been funded by the National Institutes of Health (NIH), the Agency for Healthcare Research and Quality (AHRQ), The U.S. Department of Health and Human Services, Health Resources and Services Administration, and the Robert Wood Johnson Foundation. She was the recipient of a career grant from NIH through which she has been building a research agenda focused on understanding the mechanisms underlying the diffusion of new medical technologies. She is currently the Principal Investigator on an AHRQ funded project to study uptake of clinical evidence by providers focusing on de-adoption of treatments that are shown to be ineffective or harmful. She is also the Principal Investigator on a project funded by the American Cancer Society Funded to study uptake of biosimilar drugs in the U.S. markets.

In March of 2020, Dr. Karaca-Mandic co-founded the University of Minnesota COVID-19 Hospitalization Tracking Project in an effort to collect and disseminate daily data on COVID-19 hospitalizations, ICU and ventilator use across all U.S. states. The project has produced numerous peer-reviewed publications, brief reports and extensive media mentions. The project also received 4 national recognitions including as a 2021 Innovation That Inspires from AACSB, two Silver Stevie Awards for the "Most Valuable Non-Profit Response" and "Most Valuable Service" from the American Business Awards, and was a finalist for the NIHCM Digital Media Award. Dr. Karaca-Mandic received a 2021 Women's Health Leadership TRUST Award for Community Engagement. 

Prior to joining the Carlson School faculty, Karaca-Mandic was Associate Professor of Health Policy and Management at the University of Minnesota’s School of Public Health.

She holds a Ph.D. in Economics from University of California at Berkeley, and BA degrees in economics and mathematics (high honors), and a concentration in public policy from Swarthmore College.

Edit Profile